UK Patent System

The most important Brexit patent fact: the EPO (European Patent Office) is NOT an EU institution — it is a separate treaty organization created under the European Patent Convention (EPC). The UK remained a full EPC member after Brexit. You can still file a European patent application at the EPO and validate it in the United Kingdom — this is completely unaffected by Brexit and remains the most common route to UK patent protection for international applicants. What Brexit did change: (1) The UK is not part of the Unified Patent Court (UPC) or Unitary Patent system (which entered into force June 1, 2023) — a Unitary Patent does NOT cover the UK; (2) Supplementary Protection Certificates (SPCs) are now administered separately by UKIPO and EU national offices — a UK SPC provides no EU protection and vice versa; (3) The EU exhaustion of rights doctrine now applies asymmetrically — the UK unilaterally continues to not block EU parallel imports into the UK, but UK sales no longer exhaust EU patent rights; (4) Cross-border enforcement between UK and EU courts is more complex due to the loss of Brussels Regulation reciprocal enforcement. The practical bottom line: if you want patent protection in both the UK and the EU, you need two separate titles — either a UK-validated EP patent + a Unitary Patent/EU national patents, or a UK national patent + separate EP coverage.

Before 2017, UK patent law followed a 'purposive construction' approach (established in Catnic and later Kirin-Amgen v. Hoechst [2004] UKHL 46): claim language was construed with a purposive (not literal) meaning, but the claims were the sole boundary of protection. A variant outside the literal claim, however similar in function, did not infringe. Actavis UK Ltd v. Eli Lilly and Co [2017] UKSC 48 changed this fundamentally. The UK Supreme Court (Lord Neuberger) held that a variant can infringe even if it falls outside the literal claim language, provided it satisfies three questions: (1) Does the variant achieve substantially the same result in substantially the same way as the invention described in the claim? (2) Would it be obvious to the person skilled in the art that the variant would achieve substantially the same result in substantially the same way? (3) Would the person skilled in the art have understood from the language of the claim, read in the context of the specification, that the patentee intended strict compliance with the literal meaning of the claim as an essential requirement? Only if the answer to (3) is 'no' (i.e., strict compliance was NOT required) will the variant infringe under the doctrine of equivalents. This mirrors the Protocol on Interpretation of Article 69 EPC. The practical effect: UK patent protection is broader post-Actavis, particularly in pharmaceutical and chemical cases. A generic or competitor that designs around the literal claim language must also show that its variant would NOT pass the three Actavis questions — a significantly higher bar than pre-2017.

Yes — software can be patented in the UK, subject to meeting the 'technical character' requirement. Section 1(2) of the UK Patents Act 1977 excludes 'programs for computers ... as such' from patentability. The phrase 'as such' is critical — it means that an invention involving software is not automatically excluded; only software that does nothing beyond the excluded subject matter itself is barred. The UK courts developed their approach through a series of cases. The Aerotel/Macrossan [2006] approach used a four-step structured inquiry. Symbian [2008] EWCA Civ 1066 clarified that software producing a 'further technical effect' — particularly if it improves the operation of the computer itself (as Symbian's OS code did by making Nokia smartphones operate faster and more reliably) — is patentable. In practice, UKIPO and UK courts now follow the EPO's 'technical character' approach: software that achieves a technical effect beyond the normal physical interaction of software and hardware can be patented. Examples of patentable software in the UK: methods of processing technical data to achieve a technical result; network communications protocols that improve network reliability or efficiency; AI/ML training methods that produce a technical effect in a technical system; embedded systems software that controls physical devices; signal processing algorithms applied to technical problems. Software that cannot be patented: pure business methods or rules (even if implemented in software); software that only presents information differently without technical effect; algorithms used purely for mathematical calculation. The UK approach is significantly more permissive than post-Alice USPTO, where many software-related claims are rejected under § 101. A software patent that fails the Alice/Mayo two-step in the US may be grantable at both UKIPO and EPO.

The UKIPO Green Channel is a free expedited examination program for patent applications related to environmentally beneficial inventions. It was introduced in May 2009. Key details: (1) Eligibility: any patent application that has an environmental benefit can request Green Channel treatment — this includes renewable energy, energy efficiency, carbon capture, sustainable materials, waste reduction, clean transportation, green building technology, water purification, and any other technology with a credible environmental benefit; (2) Cost: completely free — there is no additional fee beyond the standard UKIPO examination fees; (3) Speed: Green Channel applications typically receive a first examination report within 9 months of the request, significantly faster than the standard 2–3 year examination timeline; (4) How to request: the applicant submits a written request with a short explanation of the environmental benefit at any point before examination begins; the request does not need to be highly technical — a simple, clear statement that the invention reduces emissions, improves energy efficiency, or provides another environmental benefit is sufficient; (5) Outcome: a granted UK patent through the Green Channel is equivalent to any other UK patent — there is no 'green patent' category; the fast-track is purely procedural. The Green Channel is one of the most generous accelerated examination programs in the world — it is free, broadly available (many different technology areas qualify), and meaningfully faster than standard examination. For climate tech startups, clean energy companies, and any company with a credible environmental story, the Green Channel is worth requesting as a matter of course.

The UK patent court system differs from the US in several important ways: (1) Two-tier court structure: the UK has two main first-instance patent courts — the Intellectual Property Enterprise Court (IPEC) for lower-value disputes (damages capped at £500,000; cost-capped proceedings; faster and cheaper) and the Patents Court (a specialist court within the Chancery Division of the High Court) for complex, high-value disputes (no cap on damages; full discovery; higher costs). Appeals go to the Court of Appeal and ultimately the UK Supreme Court. There is no specialist appellate court equivalent to the US Federal Circuit — the Court of Appeal is a general appellate court that also hears patent cases; (2) No jury trials: UK patent cases are heard by specialist IP judges (including the patents judges and IPEC judges), not juries. Judges issue detailed reasoned judgments with more nuanced analysis than US jury verdicts; (3) Invalidity standard: in the UK, the standard of proof for invalidity in litigation is the civil standard — balance of probabilities (more likely than not). This is lower than the US 'clear and convincing evidence' standard (Microsoft v. i4i, S.Ct. 2011). UK invalidity is easier to prove than in the US; (4) No PTAB equivalent: the UK does not have an equivalent to the USPTO's Patent Trial and Appeal Board (PTAB) or inter partes review (IPR) proceedings. Post-grant invalidity challenges are adjudicated in the IPEC or Patents Court as invalidity counterclaims or revocation actions; the UKIPO also offers a non-binding opinion service. This makes invalidity challenges in the UK more expensive (litigation cost) but the absence of an IPR-like estoppel doctrine makes the playing field different; (5) Loser pays: UK courts follow the general 'costs follow the event' rule — the loser typically pays a portion of the winner's legal costs. This creates a strong deterrent to weak claims and weak defenses in UK patent litigation; (6) Preliminary injunctions (PI): UK courts apply the American Cyanamid test (serious question + balance of convenience + adequacy of damages). PIs are available but UK courts are generally less liberal with them than German courts; (7) Time to trial: IPEC claims typically go to trial within 12–18 months; Patents Court cases may take 2–4 years.